Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Adaptive Radiation Therapy for Pelvic Genitourinary Cancer

NCT03909893 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03909893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03909893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Adaptive Radiation Therapy for Pelvic Genitourinary Cancer
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2023
Completion date
January 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, prostate cancer